The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Effects of metformin on weight loss: potential mechanisms
Abstract
PURPOSE OF REVIEW: Despite the known glucose-lowering effects of metformin, more recent clinical interest lies in its potential as a weight loss drug. Herein, we discuss the potential mechanisms by which metformin decreases appetite and opposes unfavorable fat storage in peripheral tissues. RECENT FINDINGS: Many individuals struggle to maintain clinically relevant weight loss from lifestyle and bariatric surgery interventions. Long-term follow-up from the Diabetes Prevention Program demonstrates that metformin produces durable weight loss, and decreased food intake by metformin is the primary weight loss mechanism. Although the effect of metformin on appetite is likely to be multifactorial, changes in hypothalamic physiology, including leptin and insulin sensitivity, have been documented. In addition, novel work in obesity highlights the gastrointestinal physiology and circadian rhythm changes by metformin as not only affecting food intake, but also the regulation of fat oxidation and storage in liver, skeletal muscle, and adipose tissue. SUMMARY: Metformin induces modest weight loss in overweight and obese individuals at risk for diabetes. A more detailed understanding of how metformin induces weight loss will likely lead to optimal co-prescription of lifestyle modification with pharmacology for the treatment of obesity independent of diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“prevent weight gain by influencing appetite regulatory pathways in the brain (8).”
From Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis (2024) · cites this paper as [8]
In the citing paper
“Aside from the mechanisms summarized in two reviews (77, 78), recent study findings indicate that GDF-15 plays an independent role in body weight change in people taking metformin.”
From GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin (2020) · cites this paper as [77]
In the citing paper
“Studies have suggested that metformin might reduce weight through appetite regulatory pathways in the brain, leading to decreased food uptake.50”
Citations
Cites
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
Flegal, K., Carroll, M., Kit, B., & Ogden, C. (2012) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.2012.39 · Cited by 5,523
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Shin, N.-R., Lee, J.-C., Lee, H.-Y., Kim, M.-S., Whon, T. W., Lee, M.-S., & Bae, J.-W. (2014) · Gut · doi:10.1136/gutjnl-2012-303839 · Cited by 1,550
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes
TODAY Study Group (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109333 · Cited by 993
Alhadeff, A. L., Rupprecht, L. E., & Hayes, M. R. (2012) · Endocrinology · doi:10.1210/en.2011-1443 · Cited by 515
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1299 · Cited by 494
Lee, A., & Morley, J. E. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00314.x · Cited by 320
AMPK as a mediator of hormonal signalling
Lim, C. T., Kola, B., & Korbonits, M. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0063 · Cited by 304
AMPK and Exercise: Glucose Uptake and Insulin Sensitivity
O'Neill, H. M. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.1.1 · Cited by 295
Cited by
Sorted by citations
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
Leptin, cardiovascular diseases and type 2 diabetes mellitus
Katsiki, N., Mikhailidis, D. P., & Banach, M. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.40 · Cited by 296
Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes
Dutta, S., Shah, R., Singhal, S., Dutta, S. B., Bansal, S., Sinha, S., & Haque, M. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s409373 · Cited by 296
Body Weight Considerations in the Management of Type 2 Diabetes
Apovian, C. M., Okemah, J., & O'Neil, P. M. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0824-8 · Cited by 253
Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia
Sartori, R., Hagg, A., Zampieri, S., Armani, A., Winbanks, C. E., Viana, L. R., Haidar, M., Watt, K. I., Qian, H., Pezzini, C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9592 · Cited by 159
van Iersel, L., Brokke, K. E., Adan, R. A. H., Bulthuis, L. C. M., van den Akker, E. L. T., & van Santen, H. M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00017 · Cited by 146
Metformin: A review of its therapeutic efficacy and adverse effects
Shurrab, N. T., & Arafa, E. A. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100186 · Cited by 145
Describing the Weight‐Reduced State: Physiology, Behavior, and Interventions
Aronne, L. J., Hall, K. D., M. Jakicic, J., Leibel, R. L., Lowe, M. R., Rosenbaum, M., & Klein, S. (2021) · Obesity · doi:10.1002/oby.23086 · Cited by 113
Protective effects of metformin on reproductive function in obese male rats induced by high-fat diet
Yan, W., Yang, M., Yu, N., Yi, T.-L., Zhang, Y., Pang, X., Cheng, D., & Yang, J. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0506-2 · Cited by 113
Muscogiuri, G., Barrea, L., Faggiano, F., Maiorino, M. I., Parrillo, M., Pugliese, G., Ruggeri, R. M., Scarano, E., Savastano, S., Colao, A., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01574-9 · Cited by 119
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Libowitz, M. R., & Nurmi, E. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.623681 · Cited by 99
Jung, S. H., Ha, K. H., & Kim, D. J. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.3.674 · Cited by 98
Correll, C. U., Sikich, L., Reeves, G. M., Johnson, J. L., Keeton, C. P., Spanos, M., Kapoor, S., Bussell, K., Miller, L., Chandrasekhar, T., et al. (2020) · World Psychiatry · doi:10.1002/wps.20714 · Cited by 99
Obesity and Erectile Dysfunction: From Bench to Clinical Implication
Moon, K. H., Park, S., & Kim, Y.-W. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180026 · Cited by 92
Metformin enhances mitochondrial biogenesis and thermogenesis in brown adipocytes of mice
Karise, I., Bargut, T. C. L., del Sol, M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.01.021 · Cited by 92
Xu, C., Liu, W., Zhang, D., Cao, X., Shi, H., & Li, X. (2017) · Aquaculture · doi:10.1016/j.aquaculture.2017.10.022 · Cited by 91
Effects of metformin in obesity treatment in different populations: a meta-analysis
Pu, R., Shi, D., Gan, T., Ren, X., Ba, Y., Huo, Y., Bai, Y., Zheng, T., & Cheng, N. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820926000 · Cited by 88
Afshari, K., Dehdashtian, A., Haddadi, N., Haj‐Mirzaian, A., Iranmehr, A., Ebrahimi, M. A., Tavangar, S. M., Faghir‐Ghanesefat, H., Mohammadi, F. S., Rahimi, N., et al. (2018) · Spinal Cord · doi:10.1038/s41393-018-0168-x · Cited by 87
Mechanisms of action of metformin with special reference to cardiovascular protection
Zilov, A. V., Abdelaziz, S. I., Alshammary, A., Zahrani, A. A., Amir, A., Khalil, S. H. A., Brand, K. M. G., Elkafrawy, N., Hassoun, A. A. K., Jahed, S. A., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3173 · Cited by 89
Allard, J. S., Perez, E. J., Fukui, K., Carpenter, P., Ingram, D. K., & Cabo, R. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.012 · Cited by 88
Solymár, M., Ivić, I. D., Pótó, L., Hegyi, P. J., Garami, A., Hartmann, P., Pétervári, E., Czopf, L., Hussain, A., Gyöngyi, Z., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207947 · Cited by 86
Metformin upregulates mitophagy in patients with T2DM: A randomized placebo‐controlled study
Bhansali, S., Bhansali, A. K., Dutta, P. R., Walia, R., & Dhawan, V. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14834 · Cited by 82
Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A., Witchel, S. F., Mousa, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad465 · Cited by 78
Shpakov, A. O. (2021) · Pharmaceuticals · doi:10.3390/ph14010042 · Cited by 83
Tang, Y., Sun, Q., Bai, X., Zhou, Y., Zhou, Q.-L., & Zhang, M. (2019) · Nutrition and Diabetes · doi:10.1038/s41387-019-0098-5 · Cited by 73
Melin, J., Forslund, M., Alesi, S., Piltonen, T., Romualdi, D., Spritzer, P. M., Tay, C. T., Pena, A., Witchel, S. F., Mousa, A., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad098 · Cited by 72
Yannas, D., Frizza, F., Vignozzi, L., Corona, G., Maggi, M., & Rastrelli, G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102221 · Cited by 68
Metformin Impairs Spatial Memory and Visual Acuity in Old Male Mice
Thangthaeng, N., Rutledge, M. A., Wong, J. M., Vann, P. H., Forster, M. J., & Sumien, N. (2017) · Aging and Disease · doi:10.14336/ad.2016.1010 · Cited by 69
MAHUTTE, N. G., Kamga-Ngandé, C., Sharma, A. M., & Sylvestre, C. V. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.04.030 · Cited by 71
Toda, K., Hitoe, S., Takeda, S., & Shimoda, H. (2016) · Heliyon · doi:10.1016/j.heliyon.2016.e00115 · Cited by 64
Chen, D., Wang, Y., Wu, K., & Wang, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061547 · Cited by 66
Ejtahed, H.-S., Tito, R. Y., Siadat, S.-D., Hasani-Ranjbar, S., Hoseini-Tavassol, Z., Rymenans, L., Verbeke, K., Soroush, A.-R., Raes, J., & Larijani, B. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0826 · Cited by 63
Practical Use of Pharmacotherapy for Obesity
Igel, L. I., Kumar, R. B., Saunders, K. H., & Aronne, L. J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.049 · Cited by 59
Derkach, K. V., Zakharova, I. O., Zorina, I. I., Bakhtyukov, A. A., Romanova, I. V., Bayunova, L. V., & Shpakov, A. O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213779 · Cited by 60
Toth, A. T., Gomez, G., Shukla, A. P., Pratt, J. S., Cena, H., Biino, G., Aronne, L. J., & Stanford, F. C. (2018) · Children · doi:10.3390/children5090116 · Cited by 57
Impact of Metformin on Exercise-Induced Metabolic Adaptations to Lower Type 2 Diabetes Risk
Malin, S. K., & Braun, B. (2016) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000070 · Cited by 56
Self-citationThe Use of Metformin to Increase the Human Healthspan
Piskovatska, V., Storey, K. B., Vaiserman, A. M., & Lushchak, O. V. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-42667-5_13 · Cited by 55
Metformin increases hepatic leptin receptor and decreases steatosis in mice
Tang, X., Li, J., Xiang, W., Cui, Y., Xie, B., Wang, X., Xu, Z., & Gan, L. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0142 · Cited by 57
Metformin: an old therapy that deserves a new indication for the treatment of obesity.
Igel, L. I., Sinha, A., Saunders, K. H., Apovian, C. M., Vojta, D., & Aronne, L. J. (2016) · Current Atherosclerosis Reports · doi:10.1007/s11883-016-0568-3 · Cited by 52
Immunometabolism and metainflammation in obesity
Romantsova, T. I., & Sych, Y. P. (2019) · Obesity and metabolism · doi:10.14341/omet12218 · Cited by 63
Obesity Pharmacotherapy in Patients With Type 2 Diabetes
Kahan, S. I., & Fujioka, K. (2017) · Diabetes Spectrum · doi:10.2337/ds17-0044 · Cited by 52
Li, Y., Tan, J., Wang, Q., Duan, C., Hu, Y., & Huang, W. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.09.011 · Cited by 53
Jacob, S., Dötsch, A., Knoll, S., Köhler, H., Rogall, E. T., Stoll, D., Tisler, S., Hühn, C., Schwartz, T., Zwiener, C., et al. (2018) · Environmental Sciences Europe · doi:10.1186/s12302-018-0179-4 · Cited by 49
The Influence of Metformin on IGF-1 Levels in Humans: A Systematic Review and Meta-Analysis
Yang, X., Kord-Varkaneh, H., Talaei, S., Clark, C. C. T., Zanghelini, F., Tan, S. C., Zarezadeh, M., Mousavi, S. M., Rahmani, J., & Zhang, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104588 · Cited by 43
Sadeghi, A., Mousavi, S. M., Mokhtari, P., Parohan, M., & Milajerdi, A. (2020) · Childhood Obesity · doi:10.1089/chi.2019.0040 · Cited by 44
Savarese, G., Butler, J., Lund, L. H., Bhatt, D. L., & Anker, S. D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab271 · Cited by 45
Weight-centric treatment of type 2 diabetes mellitus
Ghusn, W., Hurtado, M. D., & Acosta, A. J. (2022) · Obesity Pillars · doi:10.1016/j.obpill.2022.100045 · Cited by 45
Turner, J. B. M., Kumar, A., & Koch, C. A. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9358-z · Cited by 41
Chang, H.-H., Moro, A., Chou, C. E. N., Dawson, D. W., French, S. W., Schmidt, A., Sinnett‐Smith, J. W., Fang, H., Hines, O. J., Eibl, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-24337-8 · Cited by 41
Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells
Du, J., Shi, H.-R., Ren, F., Wang, J.-L., Wu, Q., Li, X., & Zhang, R. (2017) · BMC Cancer · doi:10.1186/s12885-017-3840-1 · Cited by 40
Alfawaz, H., Wani, K., Alnaami, A. M., Al‐Saleh, Y., Aljohani, N., Al-Attas, O. S., Alokail, M. S., Kumar, S., & Al‐Daghri, N. M. (2018) · Nutrients · doi:10.3390/nu10030383 · Cited by 41
Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species
Jeong, Y., & Jusko, W. J. (2021) · Pharmaceuticals · doi:10.3390/ph14060545 · Cited by 43
GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Peng, X., Chen, Y., & Routy, J.-P. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.581839 · Cited by 39
The Effects of Metformin on Obesity-Induced Dysfunctional Retinas
Kim, A. J., Chang, J. Y.-A., Shi, L., Chang, R. C.-A., Ko, M. L., & Ko, G. Y.-P. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20691 · Cited by 38
Anoveros‐Barrera, A., Bhullar, A. S., Stretch, C., Esfandiari, N., Dunichand‐Hoedl, A. R., Martins, K. J. B., Bigam, D. L., Khadaroo, R. G., McMullen, T. P. W., Bathe, O. F., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12466 · Cited by 34
Mbara, K. C., Mato, P. E. M., Driver, C., Nzuza, S., Mkhombo, N. T., Gcwensa, S. K., Mcobothi, E. N., & Owira, P. M. O. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.173934 · Cited by 36
Zhang, Y., Liu, Y., Liu, X., Yuan, X., Xiang, M., Liu, J., Zhang, L., Zhu, S., Lu, J., Tang, Q., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2297268 · Cited by 34
Subramaniam, K., Joseph, M. P., & Babu, L. A. (2021) · Clinical Diabetes · doi:10.2337/cd20-0101 · Cited by 34
Feast and famine: Adipose tissue adaptations for healthy aging
Lettieri‐Barbato, D., & Aquilano, K. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.007 · Cited by 35
Rahmani, J., Manzari, N., Thompson, J., Gudi, S. K., Chhabra, M., Naik, G., Mousavi, S. M., Varkaneh, H. K., Clark, C. C. T., & Zhang, Y. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-019-02108-9 · Cited by 34
Emerging treatments for severe obesity in children and adolescents
Coles, N., Birken, C. S., & Hamilton, J. K. (2016) · BMJ · doi:10.1136/bmj.i4116 · Cited by 35
Wang, H., Yang, J., Chen, X., Qiu, F., & Li, J. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.01.001 · Cited by 34
Biondo, L. A., Teixeira, A. A. S., Ferreira, K. C. D. O. S., & Neto, J. C. R. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200122124116 · Cited by 31
Abbasi, M., Fan, Z., Dawson, J., & Wang, S. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040879 · Cited by 31
Metformin Plus Caloric Restriction Show Anti-epileptic Effects Mediated by mTOR Pathway Inhibition
Rubio, C., Ramírez, V. C., Gámez, D. C., Paz, C., Carvajal, K., & Phillips-Farfán, B. V. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0611-8 · Cited by 31
Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention
Seabloom, D. E., Galbraith, A. R., Haynes, A. M., Antonides, J. D., Wuertz, B. R. K., Miller, W. A., Miller, K. A., Steele, V. E., Miller, M. S., Clapper, M. L., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0232 · Cited by 30
The effects of metformin on simple obesity: a meta-analysis
Hong-Hong, N., Le, J., Wang, Q., Young, C. A., Deng, B., Gao, P., Zhang, H.-Q., & Qin, S.-L. (2018) · Endocrine · doi:10.1007/s12020-018-1717-y · Cited by 30
Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?
Green, C., Marjot, T., Tomlinson, J., & Hodson, L. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13592 · Cited by 29
Luo, C., Wang, X., Huang, H., Mao, X., Zhou, H., & Liu, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00371 · Cited by 30
Sudlow, A. C., le Roux, C. W., & Pournaras, D. J. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04206-7 · Cited by 32
Weng, S., Luo, Y., Zhang, Z., Su, X., & Peng, D. (2020) · Endocrine · doi:10.1007/s12020-020-02190-y · Cited by 31
Metformin May Contribute to Inter-individual Variability for Glycemic Responses to Exercise
Malin, S. K., & Stewart, N. R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00519 · Cited by 33
Self-citationKim, H. K., Jeong, J., Kang, E. Y., & Go, G. (2020) · Nutrients · doi:10.3390/nu12092546 · Cited by 34
Pascual‐Morena, C., Cavero‐Redondo, I., Álvarez‐Bueno, C., Lucerón‐Lucas‐Torres, M., Sanabria‐Martínez, G., Poyatos‐León, R., Rodríguez‐Martin, B., & Martínez‐Vizcaíno, V. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163490 · Cited by 28
Progress in the application and mechanism of metformin in treating non-small cell lung cancer
Li, C., Yang, X., Xi, Y.-R., & Xie, K. (2017) · Oncology Letters · doi:10.3892/ol.2017.5862 · Cited by 26
Metformin and health outcomes: An umbrella review of systematic reviews with meta‐analyses
Li, X., Celotto, S., Pizzol, D., Gašević, D., Ji, M., Barnini, T., Solmi, M., Stubbs, B., Smith, L., Sánchez, G. F. L., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13536 · Cited by 27
Yarigholi, F., Bahardoust, M., Mosavari, H., Tehrani, F. M., Gholizadeh, H., Shahmiri, S. S., Rezvani, H., Oshidari, B., Garakani, K., & Eghbali, F. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06322-3 · Cited by 25
Abrat, O., Storey, J. M., Storey, K. B., & Lushchak, V. I. (2017) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2017.10.011 · Cited by 28
Igel, L. I., Saunders, K. H., & Fins, J. J. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0740-z · Cited by 25
Vangaveti, S., Das, P., & Kumar, V. L. (2020) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22614 · Cited by 25
Qiu, Y., Gao, X., Chen, R., Lu, S., Wan, X., Farag, M. A., & Zhao, C. (2022) · Food Chemistry X · doi:10.1016/j.fochx.2022.100316 · Cited by 25
Metabolically Healthy Obesity: Are Interventions Useful?
Mathis, B. J., Tanaka, K., & Hiramatsu, Y. (2023) · Current Obesity Reports · doi:10.1007/s13679-023-00494-4 · Cited by 27
Forcato, S., Novi, D. R. B. S., Costa, N. O., Borges, L. I., de Góes, M. L. M., Ceravolo, G. S., & Gerardin, D. C. C. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2017.08.023 · Cited by 25
Kang, D., Jing, Z., Li, R., Hei, G., Shao, T., Li, L., Sun, M., Yang, Y., Wang, Y., Wang, X., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00620 · Cited by 23
A Possible Mechanism of Metformin in Improving Insulin Resistance in Diabetic Rat Models
Li, M., Hu, X., Xu, Y., Hu, X., Zhang, C., & Pang, S. (2019) · International Journal of Endocrinology · doi:10.1155/2019/3248527 · Cited by 23
Ranjbar, S., Nekooeian, A. A., Tanideh, N., Koohi‐Hosseinabadi, O., Masoumi, S. J., Amanat, S., Azarpira, N., & Monabati, A. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13242 · Cited by 23
Maksoud, H. A. A., Zaid, O. A. R. A., Elharrif, M. G., Omnia, M. A., & Alaa, E. A. (2020) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2020.07.016 · Cited by 22
Tirzepatide—Friend or Foe in Diabetic Cancer Patients?
Samuel, S. M., Varghese, E., Kubatka, P., & Büsselberg, D. (2022) · Biomolecules · doi:10.3390/biom12111580 · Cited by 22
Šestan-Peša, M., & Horváth, T. L. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.12.003 · Cited by 21
Management of Diabetes in Patients Undergoing Bariatric Surgery
Mulla, C. M., Baloch, H. M., & Hafida, S. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1242-2 · Cited by 24
Su, S., Chien, C., Chen, Y., Chiang, C., Lin, F., Kuo, F., Huang, C., Li, P., Liu, J., Lu, C., et al. (2022) · BioFactors · doi:10.1002/biof.1872 · Cited by 22
Stanford, F. C. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.10.020 · Cited by 22
Hurren, K. M., & Dunham, M. W. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1494727 · Cited by 20
Normoglycemic ketoacidosis in a postoperative gastric bypass patient taking canagliflozin
Bonanni, F. B., Fei, P., & Fitzpatrick, L. L. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.08.502 · Cited by 21
The effect of metformin on morphine analgesic tolerance and dependence in rats
Kaeidi, A., Fatemi, I., Amirteimoury, M., & Shamsizadeh, A. (2018) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.235158 · Cited by 21
Espe, M., Xie, S., Chen, S., Pedro, A., & Holen, E. (2019) · Aquaculture Nutrition · doi:10.1111/anu.12905 · Cited by 21
The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics
Agalliu, I., Williams, S. K., Adler, B., Androga, L. A., Siev, M., Lin, J., Xue, X., Huang, G. S., Strickler, H. D., & Ghavamian, R. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0554-z · Cited by 20
Liu, Q.-Q., Xia, R., Deng, X., Yang, H., Luo, L., Lin, S., Chuan-Jie, Q., & Chen, Y. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739582 · Cited by 20
Jacob, S., Köhler, H., Tisler, S., Zwiener, C., & Triebskorn, R. (2019) · Frontiers in Environmental Science · doi:10.3389/fenvs.2019.00045 · Cited by 22
Clinical review: Guide to pharmacological management in pediatric obesity medicine
O’Hara, V. M., Cuda, S. E., Kharofa, R. Y., Censani, M., Conroy, R., & Browne, N. T. (2023) · Obesity Pillars · doi:10.1016/j.obpill.2023.100066 · Cited by 22
Metadata
- Authors
- Malin, S. K., & Kashyap, S. R.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Kashyap, Sangeeta R.
- Venue
- Current Opinion in Endocrinology, Diabetes & Obesity
- Published
- 2014-10
- Volume
- 21
- Issue
- 5
- Pages
- 323-329
- ISSN
- 1752-296X (ISSN-L)
- OpenAlex
- W2118790125
- Cited by
- 223
- References
- 43
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 16 · 2023: 18 · 2022: 16 · 2021: 33 · 2020: 27 · 2019: 27 · 2018: 34 · 2017: 15 · 2016: 12 · 2015: 10
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Endocrinology Diabetes and Obesity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK089547)
- National Center for Research Resources (K12RR023264)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- metformin, weight loss, obesity, appetite, dietary intake, leptin, insulin sensitivity, fat oxidation, fat deposition, circadian rhythm, digestive physiology, diabetes prevention, lifestyle modification
- MeSH terms
- Appetite Depressants, Diabetes Mellitus, Type 2, Eating, Humans, Hypoglycemic Agents, Hypothalamus, Insulin Resistance, Metformin, Obesity, Signal Transduction, Weight Loss, Treatment Outcome, Leptin, Risk Reduction Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review